---
figid: PMC3192435__nihms-320178-f0002
figlink: /pmc/articles/PMC3192435/figure/F2/
number: Figure 2
caption: 'Targeting the PI3K/Akt/mTOR pathway to treat lymphoma. Pharmacological inhibition
  of mTORC1 with rapalogs has produced clinical responses in patients with relapsed
  non-Hodgkin lymphoma and classic Hodgkin lymphoma. Second-generation mTOR inhibitors
  and inhibitors of upstream molecules such as Akt and PI3K are currently in clinical
  trials. Frequently, cancer cells have several activated survival pathways, including
  the MEK/ERK, NF-κB, and JAK/STAT pathways. A combination of small molecules may
  be required to target these pathways. Abbreviations: ERK, extracellular signal-regulated
  kinase; JAK, Janus kinase; MEK, mitogen-activated protein kinase; mTOR, mammalian
  target of rapamycin; NF-κB, nuclear factor-kappa-B; PI3K, phosphatidylinositol 3-kinase;
  STAT, signal transducer and activator of transcription; TSC, tuberous sclerosis
  complex. Reproduced from Hematology by Anas Younes. Copyright 2009 from the American
  Society of Hematology (ASH). Reproduced with permission of American Society of Hematology
  (ASH) in the format Journal via Copyright Clearance Center.'
pmcid: PMC3192435
papertitle: 'Beyond chemotherapy: new agents for targeted treatment of lymphoma.'
reftext: Anas Younes. Nat Rev Clin Oncol. ;8(2):85-96.
pmc_ranked_result_index: '150977'
pathway_score: 0.95482
filename: nihms-320178-f0002.jpg
figtitle: Targeting the PI3K/Akt/mTOR pathway to treat lymphoma
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3192435__nihms-320178-f0002.html
  '@type': Dataset
  description: 'Targeting the PI3K/Akt/mTOR pathway to treat lymphoma. Pharmacological
    inhibition of mTORC1 with rapalogs has produced clinical responses in patients
    with relapsed non-Hodgkin lymphoma and classic Hodgkin lymphoma. Second-generation
    mTOR inhibitors and inhibitors of upstream molecules such as Akt and PI3K are
    currently in clinical trials. Frequently, cancer cells have several activated
    survival pathways, including the MEK/ERK, NF-κB, and JAK/STAT pathways. A combination
    of small molecules may be required to target these pathways. Abbreviations: ERK,
    extracellular signal-regulated kinase; JAK, Janus kinase; MEK, mitogen-activated
    protein kinase; mTOR, mammalian target of rapamycin; NF-κB, nuclear factor-kappa-B;
    PI3K, phosphatidylinositol 3-kinase; STAT, signal transducer and activator of
    transcription; TSC, tuberous sclerosis complex. Reproduced from Hematology by
    Anas Younes. Copyright 2009 from the American Society of Hematology (ASH). Reproduced
    with permission of American Society of Hematology (ASH) in the format Journal
    via Copyright Clearance Center.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - TSC2
  - STAT5A
  - RPTOR
  - AKT1
  - STAT3
  - RPS6KB1
  - MAPKAP1
  - MAP2K1
  - AKT3
  - STAT1
  - RHEB
  - KRAS
  - STAT5B
  - AKT2
  - TSC1
  - STAT2
  - NRAS
  - EIF4EBP1
  - STAT6
  - MAPK1
  - MAPK3
  - MAP2K2
  - TYK2
  - HRAS
  - RICTOR
  - JAK1
  - JAK2
  - JAK3
  - MLST8
  - STAT4
  - temsirolimus
  - ridaforolimus
  - AZD8055
  - Cancer
genes:
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: S6K1
  symbol: S6K1
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK/STAT
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: JAK/STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
chemicals:
- word: temsirolimus
  source: MESH
  identifier: C401859
- word: ridaforolimus
  source: MESH
  identifier: C515074
- word: AZD8055
  source: MESH
  identifier: C546624
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
